Trials / Withdrawn
WithdrawnNCT00162526
Tocopherol is a Novel Treatment for Cancer Related Mucositis
A Randomized Double Blind Placebo Controlled Clinical Trial Aim to Assess the Efficacy of Vitamin E Formulation (Tocopherol) in the Treatment of Chemotherapy Induced Stomatitis in Patients Undergoing Stem Cell Transplantation
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The present protocol is an attempt to prevent/treat mucositis in highly susceptible patients subjected to maximally tolerated doses of subsequently-myeloablative or myeloablative doses of chemoradiotherapy supported by autologous or allogeneic stem cell transplantation at the Department of Bone Marrow Transplantation. Mucositis is a major problem in the management of transplant recipients which subjects the patients to the risk of sepsis, need for parenteral nutrition and need of narcotics. We are planning a 2 arm study, comparing 2 safe vitamin E based formulations with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tocopherol |
Timeline
- Start date
- 2005-12-01
- First posted
- 2005-09-13
- Last updated
- 2011-04-08
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00162526. Inclusion in this directory is not an endorsement.